Skip to content

S. 5797 · 119th Congress (2025–2027)

A bill to require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is S. 5797’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. Michael F. Bennet (D-CO)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Sen. John Cornyn (R-TX)· Original · Nov 19, 2026

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Finance.

    Sources

Committees

  1. SenateFinanceReferred Nov 19, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Titles (1)
  1. A bill to require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.

    Display title, Official title · Introduced